Authors: Ceiry Fox Amy Sinclair Sarah Palmer

null

Clinical trials play a critical role in developing vaccines and other life-saving treatments, and the demand for advanced technologies such as gene therapy and artificial intelligence is increasing. Insurance carriers are monitoring the latest developments closely as securing comprehensive and compliant insurance coverage for trials has become paramount. Read our whitepaper to learn more about how the insurance industry navigates this ever-changing landscape.

VIEW WHITEPAPER

Author Information


Disclaimer

The information contained herein is offered as insurance Industry guidance and provided as an overview of current market risks and available coverages and is intended for discussion purposes only. This publication is not intended to offer legal advice or client-specific risk management advice. Any description of insurance coverages is not meant to interpret specific coverages that your company may already have in place or that may be generally available. General insurance descriptions contained herein do not include complete Insurance policy definitions, terms, and/or conditions, and should not be relied on for coverage interpretation. Actual insurance policies must always be consulted for full coverage details and analysis.

Gallagher publications may contain links to non-Gallagher websites that are created and controlled by other organizations. We claim no responsibility for the content of any linked website, or any link contained therein. The inclusion of any link does not imply endorsement by Gallagher, as we have no responsibility for information referenced in material owned and controlled by other parties. Gallagher strongly encourages you to review any separate terms of use and privacy policies governing use of these third party websites and resources.

Insurance brokerage and related services provided by Arthur J. Gallagher Risk Management Services, LLC. (License Nos. 100292093 and/or 0D69293).